Suicide Prevention Among Recipients of Care (SPARC)

July 6, 2023 updated by: Anna Radin, St. Luke's Health System, Boise, Idaho

Comparing the Effectiveness of Safety Planning Plus Follow-Up From a Suicide Prevention Hotline (SPI+) vs Safety Planning Plus Caring Contacts (SP+CC) Among Adults and Adolescents at Risk for Suicide in Primary Care or Emergency Departments

Randomized controlled trial to determine the best brief suicide prevention intervention for adults and adolescents who screen positive for suicidal ideation or behavior in emergency departments or primary care clinics.

Aim 1: Compare the effectiveness of two brief suicide prevention interventions (safety planning intervention plus structured phone-based follow-up from a suicide prevention hotline (SPI+), versus safety planning intervention plus caring contacts (CC)) to (a) reduce suicidal ideation and behavior, (b) reduce loneliness, (c) reduce return to care for suicidality, and (d) increase uptake of outpatient mental healthcare services over 12 months among adult and adolescent patients screening positive for suicide in emergency departments (EDs) and primary care clinics.

Aim 2: Assess the acceptability of connection and support planning and the safety planning intervention, with or without follow-up among providers and clinical staff in EDs and primary care clinics.

Aim 3: Assess the acceptability of SPI+ and SP+CC among adult and adolescent patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

1520

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Anna K Radin, DrPH, MPH
  • Phone Number: 208-381-8468
  • Email: Radina@slhs.org

Study Contact Backup

Study Locations

    • Idaho
      • Boise, Idaho, United States, 83712
        • St. Luke's Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient at St. Luke's Health System Emergency Department or Primary Care Clinic
  • 12-17 years old (adolescents) or 18+ years old (adults)
  • Screened positive for suicide risk on C-SSRS (any response of "yes") during current visit, or current visit is related to a suicide attempt
  • Access to a phone for the duration of the study with the ability to receive calls
  • The ability to send and receive email messages (required) and text messages (optional)
  • English or Spanish speaking and reading

Exclusion Criteria:

  • Unable or unwilling to provide informed consent to participate
  • Inappropriate for study participation based on the clinical judgment of provider

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SPI+: Safety Planning Intervention plus structured phone-based follow-up
The Safety Planning Intervention (SPI+) includes safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus a structured telephone-based intervention from a suicide prevention hotline
Suicide prevention hotline follow-up specialists will call participants to (1) conduct a brief suicide risk assessment; (2) review and discuss the participant's connection and support plan or safety plan; and (3) provide referrals to social services or other support with treatment engagement, if indicated. Participants will receive at least one and optional additional phone calls, generally delivered according to the following schedule: days 3, 7, 14, 30, 60, 90. Modifications may be made to the schedule due to weekends, holidays, or participant availability, and additional calls may be scheduled as desired by the participant. The follow-up will stop once the participant is successfully engaged in outpatient treatment or does not desire further follow-up support.
Other Names:
  • phone-based follow-up, brief contact intervention
Experimental: Caring Contacts: Safety Planning Intervention plus Caring Contacts (SP+CC)
SP+CC will include safety planning (moderate or high risk for suicide) or connection & support planning (low risk for suicide) at the clinic or ED, plus caring text messages or emails from a suicide prevention hotline.
SP+CC follow-up includes one phone conversation with a suicide prevention hotline follow-up specialist and a series of personalized caring messages sent over the course of 12 months via text or email (based on participant preference). Caring contacts will generally be sent according to the following schedule: 3 in the first week, 6 weekly, 6 bi-weekly, 4 monthly; 2 bi-monthly, and one each for the participant's birthday, Thanksgiving, Christmas, and New Year's (total of 25 over 12 months). Slight variation in the schedule is allowed. There is no expectation that participants respond to the text messages; if they do, follow-up specialists reply to any incoming texts. Replies are individually-tailored and caring.
Other Names:
  • Brief contact intervention, text-based follow-up, email follow-up

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment)
Time Frame: 6 months
6-item questionnaire with yes/no response options. Scores range from 0 (no risk) to 6 (high risk)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale
Time Frame: 6 months
5-item questionnaire with Likert scale response options (1=never, 5=always). Scores range from 5 (no loneliness) to 25 (high levels of loneliness).
6 months
Loneliness; measured using the NIH Toolbox Emotion Batteries Loneliness Scale
Time Frame: 12 months
5-item questionnaire with Likert scale response options (1=never, 5=always). Scores range from 5 (no loneliness) to 25 (high levels of loneliness).
12 months
Utilization of Emergency Department for Suicidality
Time Frame: 6 months
Measured through self-report
6 months
Utilization of Emergency Department for Suicidality
Time Frame: 12 months
Measured through self-report
12 months
Attendance at Outpatient Behavioral Health Appointments
Time Frame: 6 months
Measured through self-report
6 months
Attendance at Outpatient Behavioral Health Appointments
Time Frame: 12 months
Measured through self-report
12 months
Suicidal Ideation & Behavior; measured using the Columbia Suicide Severity Rating Scale (C-SSRS) since-last-contact screener (self-assessment)
Time Frame: 12 months
6-item questionnaire with yes/no response options. Scores range from 0 (no risk) to 6 (high risk)
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2021

Primary Completion (Estimated)

July 16, 2024

Study Completion (Estimated)

July 16, 2024

Study Registration Dates

First Submitted

April 28, 2021

First Submitted That Met QC Criteria

May 14, 2021

First Posted (Actual)

May 19, 2021

Study Record Updates

Last Update Posted (Actual)

July 7, 2023

Last Update Submitted That Met QC Criteria

July 6, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

After publication of the final research report, de-identified data may be shared with other researchers.

IPD Sharing Time Frame

Data are estimated to become available in 2026.

IPD Sharing Access Criteria

A data access committee will review and make decisions on all requests to access data.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent

Clinical Trials on SPI+

3
Subscribe